About our scientific journals

Commercial Projects Director Multiple Sclerosis EMEA at Genzyme

The MS Journal makes a substantial contribution

We are very happy with our collaboration with Medix in the Netherlands. Because of this The Multiple Sclerosis Journal is available to a large group of neurologists. Our mission is ‘Advances in healthcare through innovation’ and puts the patient is at the center stage.  The Multiple Sclerosis Journal can make a substantial contribution to the improvement of the treatment of MS-patients.

Follow us